Caitong International Asset Management Co., LTD Pliant Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $144 Billion
- Q3 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 2,047 shares of PLRX stock, worth $3,541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,047
Previous 5,548
63.1%
Holding current value
$3,541
Previous $6.44 Million
52.92%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PLRX
# of Institutions
113Shares Held
58.9MCall Options Held
209KPut Options Held
102K-
Tang Capital Management LLC San Diego, CA6MShares$10.4 Million0.4% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.5MShares$7.79 Million0.03% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.34MShares$7.51 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.51MShares$6.07 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $84.2M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...